Posttrial Treatments
| Treatment option | [177Lu]Lu-PSMA-617 arm* (n = 20) | Docetaxel arm (n = 20) |
|---|---|---|
| Docetaxel | 6 (30) | 0 (0) |
| Abiraterone | 1 (5) | 3 (15) |
| Enzalutamide | 5 (25) | 9 (45) |
| Rucaparib | 1 (5) | 0 (0) |
| Carboplatin | 1 (5) | 0 (0) |
| [177Lu]Lu-PSMA-617 | 0 (0) | 1 (5) |
| [225Ac]Ac-PSMA-617 | 1 (5) | 0 (0) |
↵* Few patients received more than one subsequent treatment.
Data are number followed by percentage in parentheses.